Genentech – FDA Approval of Polivy ® Combination for Treatment of Certain Types of Previously Untreated Diffuse Large B-Cell Lymphoma
Dr. Christopher Flowers, M.D., Department of Lymphoma – Myeloma, Division of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center and POLARIX clinical trial investigator, shares his perspectives on the recent FDA approval of Polivy (polatuzumab vedotin-piiq) in combination with R-CHP as a first-line treatment for adults with certain types of diffuse large B-cell lymphoma (DLBCL), an aggressive blood cancer and the most common form of non-Hodgkin’s lymphoma in the U.S. For more information please visit www.lymphoma.org or lls.org.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Flowers is a globally recognized leader in lymphoma clinical and population science research as well as a national leader in hematology and medical oncology.
He serves as an oncologist specializing in the treatment of lymphoma and professor at the MD Anderson Cancer Center at The University of Texas
He served as the co-senior author on POLARIX trial and has authored over 300 articles published in multiple top peer-reviewed journals.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
